|
Market Closed -
NYSE
01:30:03 28/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 325.37 USD | -1.40% |
|
-5.21% | -3.67% |
| 21/10 | Cencora to buy American Oncology Network in $2.4 billion deal | RE |
| 21/10 | Baird Adjusts Price Target on Cencora to $375 From $373 | MT |
| Market Cap | 6.21TCr 5.57TCr 5.15TCr 4.67TCr 8.72TCr 5,89800Cr 8.83TCr 62TCr 24TCr 3,09100Cr 23TCr 23TCr 9,80300Cr | P/E 2026 * |
17.8x | P/E 2027 * | 19.7x |
|---|---|---|---|---|---|
| Enterprise Value | 6.95TCr 6.24TCr 5.76TCr 5.22TCr 9.77TCr 6,60400Cr 9.89TCr 69TCr 27TCr 3,46200Cr 26TCr 26TCr 10,97700Cr | EV / Sales 2026 * |
0.21x | EV / Sales 2027 * | 0.19x |
| Free-Float |
61.21% | Yield 2026 * |
0.73% | Yield 2027 * | 0.75% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| COR | Delayed | |
CBOE
| COR | Real-time | |
|
Mexican S.E.
| COR * | End-of-day quote | |
|
London S.E.
| 0HF3 | Delayed | |
|
Tradegate
| ABG | Real-time | |
|
Boerse Muenchen
| ABG | Real-time | |
|
Deutsche Boerse AG
| ABG | Delayed | |
|
Börse Stuttgart
| ABG | Delayed | |
|
Xetra
| ABG | Delayed | |
|
Wiener Boerse
| ABC | End-of-day quote | |
|
Borsa Italiana
| 1COR | End-of-day quote |
Last Transcript: Cencora, Inc.
| 1 day | -1.40% | ||
| 1 week | -5.21% | ||
| Current month | +8.37% | ||
| 1 month | +6.01% | ||
| 3 months | +4.57% | ||
| 6 months | +4.90% | ||
| Current year | -3.67% |
| 1 week | 325 |  | 344.43 |
| 1 month | 295.01 | | 345.46 |
| Current year | 244.82 | | 376.92 |
| 1 year | 244.82 | | 377.54 |
| 3 years | 182.75 | | 377.54 |
| 5 years | 113.68 | | 377.54 |
| 10 years | 68.7 | | 377.54 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Mauch
CEO | Chief Executive Officer | 59 | 01/10/2024 |
Eva Boratto
DFI | Director of Finance/CFO | 59 | 29/06/2026 |
Pawan Verma
CTO | Chief Tech/Sci/R&D Officer | 50 | 04/11/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Lon Greenberg
BRD | Director/Board Member | 75 | 16/05/2013 |
Robert Mauch
BRD | Director/Board Member | 59 | 01/10/2024 |
D. Mark Durcan
CHM | Chairman | 64 | 01/10/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 01/10/26 | Other | Director | 275 | 0.0001% | ||
| 01/10/26 | Sell | Controller/Auditor | -986 | 0.0005% | ||
| 01/10/26 | Other | Director | 197 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.40% | -5.21% | -3.18% | +73.40% | 6.3TCr | |
| -1.70% | +0.63% | -18.93% | +11.04% | 18TCr | |
| -1.54% | -0.98% | -21.45% | +15.09% | 12TCr | |
| -0.89% | -0.72% | -0.19% | +35.32% | 12TCr | |
| +3.89% | +20.80% | -42.56% | +8.20% | 8.99TCr | |
| -0.38% | -0.91% | +10.24% | +83.35% | 5.54TCr | |
| -0.69% | +0.63% | +4.27% | -22.48% | 5.35TCr | |
| -1.57% | +0.60% | -13.31% | +43.41% | 4.49TCr | |
| -0.66% | +3.26% | -4.83% | -8.81% | 3.39TCr | |
| -0.01% | -8.37% | +11.23% | -12.02% | 2.96TCr | |
| Average | -0.50% | +1.57% | -7.87% | +22.65% | 7.85TCr | |
| Weighted average by Cap. | -0.62% | +2.03% | -12.27% | +22.85% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 34TCr 30TCr 28TCr 25TCr 47TCr 32,01300Cr 48TCr 3,34900Cr 1,33000Cr 16,78000Cr 1,26500Cr 1,23800Cr 53,21100Cr | 35TCr 32TCr 29TCr 26TCr 49TCr 33,40500Cr 50TCr 3,49400Cr 1,38800Cr 17,50900Cr 1,32000Cr 1,29200Cr 55,52500Cr |
| Net income | 358.02Cr 321.33Cr 296.7Cr 269.05Cr 502.86Cr 34TCr 509.04Cr 3.56TCr 1.41TCr 18TCr 1.34TCr 1.32TCr 57TCr | 284.5Cr 255.34Cr 235.77Cr 213.8Cr 399.59Cr 27TCr 404.5Cr 2.83TCr 1.12TCr 14TCr 1.07TCr 1.05TCr 45TCr |
| Net Debt | 743.71Cr 667.48Cr 616.32Cr 558.89Cr 1.04TCr 71TCr 1.06TCr 7.39TCr 2.93TCr 37TCr 2.79TCr 2.73TCr 1,17400Cr | 594.61Cr 533.66Cr 492.76Cr 446.84Cr 835.15Cr 56TCr 845.41Cr 5.91TCr 2.35TCr 30TCr 2.23TCr 2.18TCr 94TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 27/26/27 | $325.37 | -1.40% | 11,23,060 |
| 26/26/26 | $330.00 | -0.30% | 9,93,480 |
| 23/26/23 | $331.00 | -2.21% | 11,68,293 |
| 22/26/22 | $338.48 | -0.57% | 11,83,276 |
| 21/26/21 | $340.43 | -0.83% | 15,14,590 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- COR Stock
Select your edition
All financial news and data tailored to specific country editions
